Fenwal, Inc.
Fenwal, Inc. is listed as the manufacturer on 39 FDA drug label records covering 12 distinct active ingredients predominantly human prescription drug products.
About Fenwal, Inc.
Fenwal, Inc. is named as the labeler on 39 FDA drug label records. Its catalogue spans 12 distinct active ingredients, led by ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND ADSOL PRESERVATION, ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE, ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION, ANTICOAGULANT SODIUM CITRATE SOLUTION. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: mean kinetic, controlled room, temperature calculated, united states, intersol platelets, only store, freezing avoid, excessive heat. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
Dosage forms and routes
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | INTRAVENOUS | 21 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
FDA drug products from Fenwal, Inc.
| Brand name | Generic | Type | Route |
|---|---|---|---|
| ACD Blood-Pack Units (PL 146 PLASTIC) | ANTICOAGULANT CITRATE DEXTROSE (ACD) | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| ADSOL RED CELL PRESERVATION | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND ADSOL PRESERVATION | HUMAN PRESCRIPTION DRUG | |
| ADSOL RED CELL PRESERVATION | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND ADSOL PRESERVATION | HUMAN PRESCRIPTION DRUG | |
| ADSOL RED CELL PRESERVATION | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND ADSOL PRESERVATION | HUMAN PRESCRIPTION DRUG | |
| ADSOL RED CELL PRESERVATION | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND ADSOL PRESERVATION | HUMAN PRESCRIPTION DRUG | |
| ADSOL RED CELL PRESERVATION | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND ADSOL PRESERVATION KIT | HUMAN PRESCRIPTION DRUG | |
| ADSOL RED CELL PRESERVATION | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND ADSOL PRESERVATION | HUMAN PRESCRIPTION DRUG | |
| ADSOL RED CELL PRESERVATION | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND ADSOL PRESERVATION | HUMAN PRESCRIPTION DRUG | |
| ADSOL RED CELL PRESERVATION | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND ADSOL PRESERVATION | HUMAN PRESCRIPTION DRUG | |
| ADSOL RED CELL PRESERVATION | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND ADSOL PRESERVATION | HUMAN PRESCRIPTION DRUG | |
| ADSOL RED CELL PRESERVATION | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND ADSOL PRESERVATION | HUMAN PRESCRIPTION DRUG | |
| ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION | HUMAN PRESCRIPTION DRUG | |
| ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION | HUMAN PRESCRIPTION DRUG | |
| ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION | HUMAN PRESCRIPTION DRUG | |
| ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION | HUMAN PRESCRIPTION DRUG | |
| ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION | HUMAN PRESCRIPTION DRUG | |
| ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION | HUMAN PRESCRIPTION DRUG | |
| ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic) | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION | HUMAN PRESCRIPTION DRUG | |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| CPD/ADSOL | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND ADSOL PRESERVATION | HUMAN PRESCRIPTION DRUG | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SOLUTION | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| InterSol | PLATELET ADDITIVE 3 | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| InterSol | PLATELET ADDITIVE 3 | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| Sodium Citrate Blood-Pack Units, (PL 146 Plastic) | ANTICOAGULANT SODIUM CITRATE SOLUTION | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| Sodium Citrate Blood-Pack Units, (PL 146 Plastic) | ANTICOAGULANT SODIUM CITRATE SOLUTION | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| Sodium Citrate Blood-Pack Units, (PL 146 Plastic) | ANTICOAGULANT SODIUM CITRATE SOLUTION | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| Solucion InterSol | SOLUCION ADITIVA PARA PLAQUETAS 3 | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
Frequently asked questions
How many FDA drug products does Fenwal, Inc. make?
39 FDA drug label records name Fenwal, Inc. as the manufacturer, covering 12 distinct active ingredients.
What active ingredients does Fenwal, Inc. produce?
The most frequent active ingredients in this portfolio are ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND ADSOL PRESERVATION, ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE, ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION, ANTICOAGULANT SODIUM CITRATE SOLUTION, PLATELET ADDITIVE 3.
Are Fenwal, Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.